[Proteomics and biomarkers for detection of endometrial carcinoma].
OBJECTIVE
The purpose of this study was to focuse on recent developments on the evolving field of biomarker discovery and validation techniques using proteomics platforms for endometrial carcinoma.


METHODS
Review.


METHODS
Department of Obstetrics and Gynecology Medical Faculty Charles University Hradec Kralove.


METHODS
The last decade has seen major changes in the technologies used to identify markers for diagnosing endometrial carcinoma. Currently the major developments were made in proteomics area. This new technology hold significant promise in identifying more robust markers for endometrial carcinoma.


CONCLUSIONS
The present review summarizes the results of clinical and experimental research on biomarkers of endometrial carcinoma.
Kacerovský
M
M
Lékarská fakulta Hradec Králové, Univerzita Karlova, Praha. kacermar@fnhk.cz
Tosner
J
J
D014408:Biomarkers, Tumor / Q000032:analysis*; D016889:Endometrial Neoplasms / Q000175:diagnosis*; D005260:Female; D006801:Humans; D009363:Neoplasm Proteins / Q000032:analysis*; D040901:Proteomics; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
D014408:Biomarkers, Tumor; D009363:Neoplasm Proteins